RV
Reena Verma
Serum Institute of India (India), National Institute of Malaria Research, Tata Institute of Fundamental Research
0000-0001-9870-6017
Employment
-
Serum Institute of India (India) Consultant (R&D)2024 - Present
-
National Institute of Malaria Research Project Research Scientist2021 - Present
Education
-
Tata Institute of Fundamental Research Post Doc2016 - 2028
Projects & Funding
Projects & funding information is unavailable.
Publications (9)
- Development of multiplexed flow based assay for simultaneous identification and estimation of meningococcal capsular polysaccharide serogroups A, C, W, Y and X for conjugate vaccine manufacturing. Save
- A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India. Save
- Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis. Save
- Targeting Plasmodium falciparum Invasion via Antibodies Against Merozoite Surface Enolase That Binds to Band 3 of Human Red Blood Cells Save
- What India can learn from globally successful malaria elimination programmes. Save
- Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase. Save
- Diagnostic potential of monoclonal antibodies developed against C-terminal polypeptide of P. falciparum Histidine Rich Protein2 (PfHRP2) in malaria infected patients from India. Save
- Adjuvant poly(N-isopropylacrylamide) generates more efficient monoclonal antibodies against truncated recombinant histidine-rich protein2 of Plasmodium falciparum for malaria diagnosis. Save
- Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum. Save